IRIS Accounts Production v26.3.0.614 OC423559 designated member 1.4.25 31.3.26 31.3.26 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhOC4235592025-03-31OC4235592026-03-31OC4235592025-04-012026-03-31OC4235592024-03-31OC4235592024-04-012025-03-31OC4235592025-03-31OC423559ns15:EnglandWales2025-04-012026-03-31OC423559ns14:PoundSterling2025-04-012026-03-31OC423559ns10:PartnerLLP12025-04-012026-03-31OC423559ns10:LimitedLiabilityPartnershipLLP2025-04-012026-03-31OC423559ns10:SmallEntities2025-04-012026-03-31OC423559ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-31OC423559ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-31OC423559ns10:LimitedLiabilityPartnershipsSORP2025-04-012026-03-31OC423559ns10:FullAccounts2025-04-012026-03-31OC423559ns10:RegisteredOffice2025-04-012026-03-31OC423559ns5:CurrentFinancialInstruments2026-03-31OC423559ns5:CurrentFinancialInstruments2025-03-31OC423559ns5:CapitalRedemptionReserve2026-03-31OC423559ns5:CapitalRedemptionReserve2025-03-31OC423559ns5:PlantMachinery2025-03-31OC423559ns5:PlantMachinery2025-04-012026-03-31OC423559ns5:PlantMachinery2026-03-31OC423559ns5:PlantMachinery2025-03-31OC423559ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-31OC423559ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31OC42355912025-04-012026-03-31
REGISTERED NUMBER: OC423559 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

FOR

SIM4MED LLP

SIM4MED LLP (REGISTERED NUMBER: OC423559)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026










Page

General Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SIM4MED LLP

GENERAL INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DESIGNATED MEMBERS: Stuart Martin Fisher





REGISTERED OFFICE: 55 Loudoun Road
St. John's Wood
London
NW8 0DL





REGISTERED NUMBER: OC423559 (England and Wales)





ACCOUNTANTS: mgr Weston Kay LLP
Chartered Accountants
55 Loudoun Road
St John's Wood
London
NW8 0DL

SIM4MED LLP (REGISTERED NUMBER: OC423559)

BALANCE SHEET
31 MARCH 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,164 1,893

CURRENT ASSETS
Debtors 5 434,602 506,039
Cash at bank 197,901 4,557
632,503 510,596
CREDITORS
Amounts falling due within one year 6 172,912 146,993
NET CURRENT ASSETS 459,591 363,603
TOTAL ASSETS LESS CURRENT LIABILITIES
and
NET ASSETS ATTRIBUTABLE TO MEMBERS 462,755 365,496

LOANS AND OTHER DEBTS DUE TO
MEMBERS

7

332,974

246,720

MEMBERS' OTHER INTERESTS
Capital accounts 170,000 170,000
Other reserves (40,219 ) (51,224 )
462,755 365,496

TOTAL MEMBERS' INTERESTS
Loans and other debts due to members 7 332,974 246,720
Members' other interests 129,781 118,776
Amounts due from members 5 (321,320 ) (325,574 )
141,435 39,922

The LLP is entitled to exemption from audit under Section 477 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 for the year ended 31 March 2026.

The members acknowledge their responsibilities for:
(a)ensuring that the LLP keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the LLP as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 relating to financial statements, so far as applicable to the LLP.

SIM4MED LLP (REGISTERED NUMBER: OC423559)

BALANCE SHEET - continued
31 MARCH 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

In accordance with Section 444 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, the Profit and loss account has not been delivered.

The financial statements were approved by the members of the LLP and authorised for issue on 13 October 2026 and were signed by:





Stuart Martin Fisher - Designated member

SIM4MED LLP (REGISTERED NUMBER: OC423559)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026


1. STATUTORY INFORMATION

Sim4Med LLP is a limited liability partnership incorporated in England and Wales. The registered office is 55 Loudoun Road, St John's Wood, London, NW8 0DL.

The limited liability partnership's principal activities are disclosed in the Members' Report.

2. ACCOUNTING POLICIES

Accounting convention
These financial statements have been prepared in accordance with the Statement of Recommended Practice "Accounting by Limited Liability Partnerships" issued in January 2017, together with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the limited liability partnership. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

IT equipment - 3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

SIM4MED LLP (REGISTERED NUMBER: OC423559)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


2. ACCOUNTING POLICIES - continued

Financial instruments
The limited liability partnership has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Basic financial assets
Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Going concern
At the time of approving the financial statements, the members have a reasonable expectation that the limited liability partnership has adequate resources to continue in operational existence for the foreseeable future. Thus the members continue to adopt the going concern basis of accounting in preparing the financial statements.

Members' participating interests
Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed remuneration and profits).

Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with section 22 of FRS 102. A member's participation rights including amounts subscribed or otherwise contributed by members, for example members' capital, are classed as liabilities unless the LLP has an unconditional right to refuse payment to members, in which case they are classified as equity.

Once an unavoidable obligation has been created in favour of members through allocation of profits or other means, any undrawn profits remaining at the reporting date are shown as ‘Loans and other debts due to members’ to the extent they exceed debts due from a specific member.

Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated

Impairment of fixed assets
At each reporting period end date, the limited liability partnership reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the limited liability partnership estimates the recoverable amount of the cash-generating unit to which the asset belongs.

SIM4MED LLP (REGISTERED NUMBER: OC423559)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


3. EMPLOYEE INFORMATION

The average number of employees during the year was NIL (2025 - NIL).

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2025 13,122
Additions 2,000
At 31 March 2026 15,122
DEPRECIATION
At 1 April 2025 11,229
Charge for year 729
At 31 March 2026 11,958
NET BOOK VALUE
At 31 March 2026 3,164
At 31 March 2025 1,893

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade debtors 53,775 150,242
Other debtors 380,827 355,797
434,602 506,039

Included in other debtors at the year end are amounts owed by members totalling £321,320 (2025: £325,574).

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade creditors 4,083 4,714
Taxation and social security 17,998 12,279
Other creditors 150,831 130,000
172,912 146,993

7. LOANS AND OTHER DEBTS DUE TO MEMBERS

In the event of a winding up the amounts included in "Loans and other debts due to members" will rank equally with unsecured creditors.

SIM4MED LLP (REGISTERED NUMBER: OC423559)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


8. RELATED PARTY DISCLOSURES

During the year, LLP was credited interest of £Nil (2025 - credited interest of £59,437) in accordance with The UK Film & Television Production Company plc Loan Agreement. The loan has been provided with terms at an arm's length basis.

9. POST BALANCE SHEET EVENTS

Subsequent to the year end, The UK Film & Television Production Company Plc (UKFTV) retired as a designated member of the LLP. Following its retirement, the LLP and UKFTV reached an agreement in respect of the amounts due to UKFTV, representing full and final settlement of its capital and loan account balances.